Category: News

Arik Zucker is one of the winners of the venture leader China program.

Amsterdam, Netherlands – Red Herring announced its Red Herring Europe award winners today, recognizing Europe’s leading private companies and celebrating these startups’ innovations and technologies across their respective industries. Red Herring’s Top 100 Europe list has become a mark of distinction for identifying promising new companies and entrepreneurs. Red Herring’s editors were among the first […]

Qvanteq AG today announced that it has enrolled the first patient in the First in Man (FiM) clinical study QUEST I, this is following earlier regulatory approval from the Dutch and Swiss authorities. The aim of the QUEST I study is to assess feasibility and safety of the Qstent, a bioactive, coating-free coronary stent. The […]

Qvanteq was amongst the “Top 100 Swiss Startups”  for the 4th time in a row.

Qvanteq won the CTI best poster award. Read more

A portrait of Qvanteq AG was published in the the Swiss business journal “Handelszeitung” under the the title “Am Puls des Herzens”.   Full article (g).

Qvanteq completed  ISO13485 Certification under the guidance of the notified body DEKRA.   View Certificate.

Series B financing round Qvanteq AG today announced the successful completion of its series B financing round of 4 million Swiss Francs which has been raised from private investors. The funds will be used to obtain clinical proof of concept in a “First-in-Man” study as well as CE market approval for Qvanteq’s own novel coronary […]

Qvanteq AG was awarded with the “CTI Start-Up Label”  in June 2012.

Qvanteq was among the finalists of the Pionierpreis 2012. 15 companies have been nominated.

A portrait of Qvanteq AG was published in the the Swiss  journal “20minuten” under the the title “Weniger Herzinfarkte dank neuer Stent-Technologie”.   Full article (g).